Sign in
4

Changes in Ownership

Kymera Therapeutics, Inc. Filed Acc 0001209191-23-003293

10% owner sold 126,474 shares at an average $30.22 ($3,821,739)

From the SEC's structured data for this filing

Trades in this filing

Atlas Venture Fund X, L.P. · 10% owner

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-11 Sale : show line 1 in the form −21,683 $29.96 $649,623 5,045,242 D
2023-01-11 Sale : show line 2 in the form −6,071 $29.96 $181,887 911,740 I
2023-01-12 Sale : show line 3 in the form −77,128 $30.29 $2,336,207 4,968,114 D
2023-01-12 Sale : show line 4 in the form −21,592 $30.29 $654,022 890,148 I
Open-market sales · 126,474 sh · avg $30.22 · $3,821,739
Loading xslF345X03/doc4.xml…